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In-person Data Collection During COVID-19:
Considerations and lessons learned from conducting mixed
methods social and behavior change research in Niger
This brief provides an overview of
considerations and lessons learned from
conducting in-person mixed methods
research in the context of COVID-19. It is
intended for global and regional public
health program implementers, evaluators,
and donors in U.S. Agency for International
Development (USAID) priority countries.
Using an applied example from the Resilience
in the Sahel Enhanced (RISE) II Integrated
Social and Behavior Change (SBC) Evaluation
carried out by Breakthrough RESEARCH,
the brief provides an overview of the
COVID-19 situation in Niger and describes
how researchers deliberated on various
data collection strategies to conduct a
mixed methods evaluation during a global
pandemic. The brief then illustrates the steps
undertaken to develop and implement a
COVID-19 phased risk mitigation approach
for in-person data collection and summarizes
lessons learned from the experience.

Background
USAID’s RISE II programs target chronically vulnerable
populations through programming that strengthens state
institutions and local governance; increases sustainable
economic well-being through agriculture and livelihood
programs; and improves priority health behaviors in
maternal, newborn, and child health, family planning,
nutrition, and water, sanitation, and hygiene. The programs are being implemented at the community and
facility levels through four Resilience Food Security
Assistance (RFSA) partners and health service delivery

KEY POINTS
Breakthrough RESEARCH considered whether,
and how to resume in-person data collection
to complete a mixed methods evaluation
planned to begin in mid-2020 in Niger.
In a resource constrained setting such as
Niger, alternatives to in-person data collection
may be limited due to weak feasibility of using
remote-based data collection methodologies.
Researchers should develop risk mitigation
approaches tailored to local contexts to ensure study teams have a plan to safely conduct
in-person data collection at each step of the
study.

mechanisms in select zones in Burkina Faso and Niger. To
support implementation, Breakthrough ACTION is providing capacity strengthening and technical assistance to the
governments, and RFSA partners to enhance the quality
and alignment of the SBC program components.

FIGURE 1 MAP OF NIGER AND RISE II
PROGRAMMATIC AREAS

Breakthrough RESEARCH, USAID’s flagship SBC research
and evaluation project led by the Population Council,
designed a mixed methods research study in the Maradi
and Zinder regions of Niger (Figure 1) to assess successes
and challenges of the RISE II integrated SBC programming, including its effectiveness on priority behaviors
and cost-effectiveness in a climate-stressed setting. The
study design included in-person in-depth interviews with
program participants and three annual cross-sectional
household surveys with an intervention and comparison
area. The study team planned to start data collection in
mid-2020.
On 11 March 2020, the World Health Organization (WHO)
declared the coronavirus a global pandemic requiring
countries to introduce travel restrictions and limit in-person activities. As a result, plans to begin data collection
for the RISE II integrated SBC evaluation were postponed
until additional information regarding transmission and
effective mitigation approaches emerged in the scientific
literature. This brief describes the COVID-19 situation
in Niger and summarizes how Breakthrough RESEARCH
1) identified an appropriate data collection strategy; 2)
developed a phased risk mitigation approach for in-person
data collection; and 3) documented lessons learned from
the experience.

COVID-19 situation in Niger
Following the WHO announcement of the global pandemic
in March 2020, Niger began reporting the number of
COVID-19 cases. Restrictions were enacted by the government in the first two months of the pandemic. However, the Government of Niger modified the restrictions
following protests in Niamey on 20 May 2020 and the
airport reopened in August 2021. The protests coincided
with growing international concern that the lockdowns
and restrictions in sub-Saharan Africa may cause a continent-wide recession making it difficult for countries to
meet health and survival needs of populations because
of reduced trading, tourism and lower levels of foreign
direct investment including foreign assistance. As of 25
August 2021, there have been 5,770 cumulative confirmed
cases of COVID-19 with 196 deaths reported by the WHO
in Niger. However, given the limited testing, this is likely to
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be an undercount. Businesses and schools are open, but it
is mandatory to wear a face mask (or face covering) in all
public places (US Embassy Niger 2020). The Government
of Niger is encouraging adherence to WHO guidelines such
as social distancing and hand washing. COVID-19 testing
is available in major cities and airports and costs approximately $50 per test for air travel. However, testing rates
are low and primarily used for international travelers.

Identifying an appropriate
strategy to conduct the RISE II
integrated SBC evaluation
We considered three options to safely achieve the RISE
II evaluation study objectives including 1) an alternative
timing to in-person data collection; 2) employing remote
data collection strategies; and 3) instituting a phased risk
mitigation approach for in-person data collection.

1. Alternative timing to in-person data
collection
We considered both eliminating the first cross-sectional
survey (i.e., baseline) and delaying in-person data collection beyond the planned start of July 2020 until more
evidence on COVID-19 transmission, risk levels, and appropriate mitigation strategies were documented. However,
conducting the baseline survey beyond the first quarter
of 2021 would prevent the study team from establishing baseline measures as study participants would have
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been exposed to the integrated SBC activities. Without a
baseline, we would not be able to provide information on
behavioral determinants, which would inform program
learning and adaptation. We would also be unable to measure changes in health outcomes over time or understand
the effectiveness of the integrated model. Given these
considerations, we determined that modifying the study
design or delaying data collection would not allow us to
achieve the RISE II evaluation study objectives.

2. Employing remote data collection strategies
We considered the use of remote data collection methods
such as using computer assisted telephone interviewing
to reduce the possibility of transmission that could occur
through in-person data collection. We first reviewed key
indicators related to mobile penetration and electricity
access and then reviewed access to mobile broadband
networks. The Central Intelligence Agency world factbook indicates that there are 46 mobile subscriptions
per 100 inhabitants in Niger and less than 5% of the rural
population has access to electricity which is necessary to
charge mobile devices. In addition, based on a 2020 GSMA
West Africa report, we determined that 82% of the Niger
population is not covered by a mobile broadband network.
Given these limitations, remote data collection techniques
that rely on telecon phone registry lists, interactive voice
response surveys, and short message service surveys
would not be viable in the RISE II context.

3. Instituting a phased risk mitigation approach
to in-person data collection
Finally, we considered a phased approach to in-person
data collection with risk mitigation approaches in place
beginning in late 2020 and continuing through the first
quarter of 2021 prior to implementation of the fully

integrated SBC approach at scale. This approach would
enable our study team to engage more cautiously and
assess the efficacy of our approaches before implementing
them on a wider scale. We proposed piloting one in-person data collection activity in one region, specifically 20
in-depth interviews. Data collection would be suspended
if a member of the research team did not follow the risk
mitigation procedures, tested positive for COVID-19, or
presented with any COVID-19 related symptoms. Similarly, study participants would be screened prior to the
interview and if they reported COVID-19 symptoms, the
interview would be suspended, and the participant would
be referred for testing. In this situation, the research team
in Niger would follow the local COVID-19 guidelines in
coordination with the Ministry of Health. If this approach
was deemed successful and no adverse events were
recorded, the team would proceed with the remaining
qualitative interviews and the quantitative household survey which would reach approximately 2,400 women and
1,200 men with risk mitigation approaches in place for all
activities. Given the study objectives and limitations with
alternative approaches, we considered the phased risk
mitigation approach to in-person data collection the most
appropriate strategy in that it enabled us to achieve the
study objectives while reducing risk for our staff and study
participants.
Once the study team agreed on the approach, we set out
to carefully and thoughtfully develop a risk mitigation
plan that would guide the phased approach to in-person
data collection. Development of the risk mitigation plan
involved the research team, led by the principal investigator and including the local field team, the project and
organizational leadership. Figure 2 provides a timeline
from the onset of COVID-19 and key events leading up to
and through the phased implementation.

FIGURE 2 BREAKTHROUGH RESEARCH RISE II INTEGRATED SBC EVALUATION STUDY TIMELINE
FOLLOWING ANNOUNCEMENT OF COVID-19 PANDEMIC
1. IRB approval for study
from Niger ethics
committee and Population
Council received
May/June 2020

1

2. COVID-19 mitigation plan
approved by Population Council
3. Qualitative interviewer training
20 in-depth interviews in Zinder
December 2020

3. 20 in-depth
interviews
in Maradi
January/
February 2021

2–4

3

5. Household survey
interviewer
training
March 2021

4

5

6

WHO declares
COVID-19 global
pandemic

4. Niger
presidential
election

4. Niger
presidential
run-off election

6. Household survey
N=2,400 women
& 1,200 men

March 2020

December 2020

February 2021

April/May 2021
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Implementing a phased risk
mitigation approach to in-person
data collection
1. Requesting institutional review board study
approval in the context of COVID-19
Breakthrough RESEARCH submitted a study application
to the Population Council institutional review board (IRB)
and the Niger Ministry of Health ethics committee in April
2020. The Niger Ministry of Health did not provide guidance or request specific mitigation strategies during their
review and provided approval in May 2020. The Population
Council IRB responded and requested mitigation strategies
to address the COVID-19 risks. The study team provided
general risk mitigation strategies that illustrated how we
would address different aspects of survey implementation
to prevent the spread of COVID-19 to the study team and
study participants. The Population Council IRB approved
the protocol with these outlined risk mitigation measures
in June 2020.

2. Developing a phased risk mitigation plan
Given the limited amount of information at the time on
COVID-19, the Population Council as an institution required
Breakthrough RESEARCH to develop a comprehensive
activity-based phased risk mitigation plan to accompany
the general measures outlined in the approved protocol.
The Breakthrough RESEARCH study team prepared the
phased risk mitigation plan for in-person data collection
using a standard template developed by the Population
Council which was approved in December 2020. The RISE
II integrated SBC risk mitigation plan records a summary
of the study activities, per the study protocol, along with
roles and responsibilities related to risk mitigation actions
for international and in country-based research staff to
carry out to ensure the safety of the research team and
study participants. Table 1 describes the inputs and considerations needed when study teams are developing the risk
mitigation plan.

3. Qualitative interviewer training and data
collection
The phased risk mitigation plan proposed staggering data
collection to allow time to reflect on how the plan was
working with the smaller qualitative data collection team
(five-member team) and sample (N=20) before advancing
to the larger quantitative household survey effort. As a
result, the data collection period for the qualitative study
4

began in the Zinder region in December, followed by a
pause in January and concluded in February prior to the
Presidential run-off elections to ensure that no adverse
events occurred following the initial data collection activities. Study participants were contacted in advance through
mobile phones to ensure that they agreed to the interview and were available before the study team traveled
to the community. We did not experience any reduced
response rates due to perceived COVID-19 risks and study
participants expressed appreciation for the medical masks
provided by the study team prior to the interview. We did
not observe any breaches in the risk mitigation plan during
the qualitative training and data collection efforts and no
illnesses were reported.

4. Monitoring community-level events (e.g.,
presidential run-off election) during
COVID-19
As shown in Figure 3 (page 6), from April through November 2020, cumulative COVID-19 cases in Niger remained
below 1,500. However, a spike in cases occurred in December and January following the 27 December presidential
election. Cases declined in February but then increased
slightly in March and April following the 22 February
presidential runoff when numerous protests took place in
Zinder region.

5. Quantitative interviewer training
The 35-member study team convened in the city of Zinder
for the quantitative training the first week of March 2021.
The study team included members from Niamey who had
received negative COVID-19 tests prior to travel and study
team members based in Zinder. At the onset of the training, several asymptomatic study team members based in
Zinder received positive COVID-19 polymerase chain reaction (PCR) tests. The study team immediately informed the
Ministry of Health and the principal investigator. The study
team was asked to quarantine for one week before a follow-up COVID-19 test could be administered ensuring that
all study team members were negative before proceeding
with the training. Follow-up tests were negative, and the
training proceeded with mitigation strategies in place as
outlined in the risk mitigation plan.

6. Quantitative data collection
Following the conclusion of the interviewer training, the
study team deployed for data collection the first week of
April. Consistent with the qualitative study experience, the
study team did not experience any reduced response rates
due to perceived COVID-19 risks and study participants
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TABLE 1 STUDY TEAM RISK MITIGATION PLAN INPUTS
Inputs

Description

Contact information

Indicates whose contact information will be collected (i.e., data collectors,
supervisors, drivers, study participants, etc.) and who will maintain this information
in case it is necessary to conduct contact tracing.

Personal protective equipment (PPE)
and related equipment

Identifies who is responsible for the procurement and distribution of PPE and
related equipment to the study team per USAID’s guidance.

Pre-event and daily attestations of
health

Provides guidance on procedures to ensure study team receives information on
COVID-19 including risks, sources of exposure, routes of transmission, how to
monitor for COVID-19 symptoms, how to use a medical mask, what to do if they
display symptoms, and whether a negative PCR COVID-19 test result is needed prior
to participating in any study-related activities.
Provides daily COVID-19 monitoring checklists for research staff to maintain
throughout the study.

Venue

Provides guidance on steps taken to ensure proper ventilation (e.g., opening
windows, carrying out activity outdoors) and maintaining social distance between
study team members and study participants.

Transportation to/from location

Provides guidance on steps taken to ensure proper ventilation (opening car
windows) and wearing a medical mask while traveling.

Food and drink

Provides guidance on steps to ensure the study team is socially distanced during
meals and there is safe distribution of food and drinks.

Lodging

Provides guidance on steps to ensure proper ventilation (opening windows),
wearing a medical mask, and maintaining social distance and whether participants
will share a room

Reporting procedures for someone who
exhibits symptoms, becomes aware they
are exposed, or tests positive during the
activity or within 14 days of its conclusion

Establishes procedures for ensuring that the Ministry of Health and study team are
notified in the event research staff display COVID-19 symptoms or tests positive for
COVID-19 and ensures that Ministry of Health guidelines are followed.

Isolation procedures for someone who
exhibits symptoms, becomes aware they
are exposed, or tests positive during the
activity or within 14 days of its conclusion

Procedures are in place to ensure that Ministry of Health guidelines are followed in
case research staff exhibit symptoms or tests positive for COVID-19.

Communication plan for regular updates
to principal investigator

Establishes procedures for daily meetings between field-based study team and
headquarters team

expressed appreciation for the medical masks provided by
the study team prior to the interview. Interviewers administered a symptom screening questionnaire to each participant prior to initiating the interview and interviewers
ended interviews with study participants who responded
yes to any of the symptoms. Quantitative data collection
concluded the first week of May and no adverse events
were reported at the conclusion of the study.

Lessons learned
Prior to data collection

•

There is not a one-size-fits-all approach to in-person
data collection in the context of COVID-19. To identify the most appropriate and effective strategy, it
is important to carefully consider all alternatives in
consultation with implementing partners, IRBs, and
ministries of health.
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FIGURE 3 WHO COVID-19 DASHBOARD: NIGER STATUS OF CUMULATIVE CASES AND DEATHS BETWEEN
MARCH 2020 AND MAY 2021
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Research teams should plan for and include time in
their workplan to thoughtfully develop risk mitigation
strategies tailored to the context of COVID-19 in which
they are proposing to work and include time for any
institutional reviews and approvals of this plan.
Study teams should include mitigation plans in IRB
applications and be prepared to communicate any
adverse events to the government, donor, institutional
leadership, and IRBs.
U.S. and field-based teams should monitor communications with the U.S. Embassy and maintain communication with the USAID in-country staff for any additional
local guidance as recommended in the USAID COVID19 implementing partner guidance frequently asked
questions.
Field-based study teams should routinely engage with
the Ministry of Health authorities to assess any changes
in an increase in cases at study sites as well as changes
in Ministry of Health regulations that restrict movement or in-person meetings.
In addition to monitoring weekly cases, programs
should consider current events and avoid initiating
in-person data collection following political events
or major holidays which may result in a temporary
increase in COVID-19 cases.

•
•

•

•

During training and data collection

•

6

Research staff should consider conducting trainings in
remote locations outside major cities to minimize interviewer transport back and forth to the training site.

•

Field-based study teams should establish communication with Ministry of Health staff and develop procedures to address adverse events that may arise during
research implementation.
Cultural barriers and biases regarding the use of
medical masks in the context of COVID-19 were not
observed during training and data collection. However,
further evidence on attitudes toward and behaviors of
COVID-19 mitigation strategies may be needed if the
general population is not observing mitigation strategies outside the study setting.
Ministry of Health policies, which prioritize the availability of PCR testing for symptomatic cases or individuals who are traveling internationally, may result
in limited availability of testing for those who are
not symptomatic particularly outside of major cities.
Researchers should consider recruiting interviewers
from areas that have routine access to testing to ensure
that all study team members are able to be tested prior
to the initiation of study activities.
Compliance with lengthy mitigation strategies may be
challenging for field-based teams working in remote
areas because supervisors are not able to continuously
monitor interviewer and study participant compliance
to proper mask wearing and social distancing requirements in a dispersed setting. While no challenges were
recorded during our study, study teams should engage
and seek input from field-based teams to ensure that
proposed mitigation strategies are feasible.
International organizations should consider local policies and procedures and determine if more stringent
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•

safety criteria should be applied to ensure the
safety of the research team.
Screening study participants for COVID-19 symptoms may create a false assurance for the interviewer and may be difficult to consistently apply
particularly for symptoms such as fatigue. Efforts
may be better spent focusing on mitigation measures (e.g., distancing, masks, hand sanitizing).

After data collection

•

Given the continuously evolving COVID-19 context,
study teams should hold after action reviews to
reflect on what went well and where improvements can be instituted going forward.
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